No Picture
News

Recursion founders gin fortunes as IPO backers shower $436M on one of the biggest boasts in AI — based on some very small deals

Bioregnum Opinion Column by John Carroll In the AI drug development world, boasting often comes with the territory. Yet few can rival Recursion when it comes to claiming the lead role in what company execs like to call the industrialization of drug development, with promises of… Click here to view original post… […]

No Picture
News

Aegis Life Announces Start of Phase 1/2 Trial of the Entos COVID-19 DNA Vaccine, Covigenix VAX-001, with First Participants Dosed

SAN DIEGO–(BUSINESS WIRE)– #COVID19–Aegis Life, Inc. announced the first participants dosed in a Phase 1/2 trial with Entos DNA vaccine Covigenix VAX-001, inducing immunity to SARS-CoV-2 Click here to view original post… […]

No Picture
News

COVID-19: Scientists identify human genes that fight infection

Research pinpoints interferon stimulating genes that control SARS-CoV-2 replication. Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also… Click here to view original post… […]

No Picture
News

Novavax CFO Greg Covino makes a quick exit as leadership carousel keeps turning; Kite execs fly away to a cell therapy upstart teaming up with Lyell

Greg Covino ? If it seems like Covid-19 vaccine bridesmaid Novavax is shuttling staffers in and out, you’re not alone. This week, Greg Covino announced he’s leaving the biotech after holding the CFO job for a blink-and-you-miss-it tenure. An advisory role within the company … […]

No Picture
News

Study Uses Precision Medicine to Speed Drug Testing for Pancreatic Cancer

Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer. Click here to view original post… […]